Search hospitals

>

New Brunswick

>

SAINT JOHN

New Brunswick Heart Centre

Claim this profile

SAINT JOHN, New Brunswick E2L 4L2

Conducts research for Heart Attack

Conducts research for Cardiovascular Risk

Conducts research for Coronary Artery Disease

Conducts research for Angina Pectoris

Conducts research for Angina

6 reported clinical trials

2 medical researchers

Photo of New Brunswick Heart Centre in SAINT JOHNPhoto of New Brunswick Heart Centre in SAINT JOHNPhoto of New Brunswick Heart Centre in SAINT JOHN

Summary

New Brunswick Heart Centre is a medical facility located in SAINT JOHN, New Brunswick. This center is recognized for care of Heart Attack, Cardiovascular Risk, Coronary Artery Disease, Angina Pectoris, Angina and other specialties. New Brunswick Heart Centre is involved with conducting 6 clinical trials across 14 conditions. There are 2 research doctors associated with this hospital, such as Zlatko Pozeg, MD and Jean-Francois Legare, MD.

Top PIs

Zlatko Pozeg, MD

Horizon Health Network

1 year of reported clinical research

Studies Pararenal Aneurysms
Studies Aortic Aneurysm
3 reported clinical trials
4 drugs studied

Jean-Francois Legare, MD

New Brunswick Heart Centre

3 years of reported clinical research

Studies Stroke
Studies Systemic Embolism
1 reported clinical trial
1 drug studied

Clinical Trials running at New Brunswick Heart Centre

Heart Attack

Cardiovascular Risk

Aortic Dissection

Dissecting Aneurysm

Image of trial facility.

Ziltivekimab

for Heart Attack

The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. Ziltivekimab might reduce development of heart disease, thereby preventing new heart attacks or strokes. Participants will either get ziltivekimab (active medicine) or placebo (a dummy medicine which has no effect on the body). Which treatment participants get is decided by chance. The chance of getting ziltivekimab or placebo is the same. The participant will need to inject the study medicine into a flat skin surface in there stomach, thigh, or upper arm once every month. Ziltivekimab is not yet approved in any country or region in the world. It is a new medicine that doctors cannot prescribe. The study will last for about 2 years.

Recruiting

1 award

Phase 3

5 criteria

Similar Hospitals nearby

Select from list below to view details

Frequently asked questions

What kind of research happens at New Brunswick Heart Centre?

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.